Cargando…

Overcoming apoptotic resistance afforded by Bcl-2 in lymphoid tumor cells: a critical role for dexamethasone

Bcl-2 is an anti-apoptotic protein that promotes cell survival and resistance to cell death. Predictably, Bcl-2 as well as other anti-apoptotic Bcl-2 family members have been found to be overexpressed in a variety of human cancers. Approaches to overcome apoptotic resistance afforded by Bcl-2 in cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bortner, Carl D., Oakley, Robert H., Cidlowski, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767920/ https://www.ncbi.nlm.nih.gov/pubmed/36539401 http://dx.doi.org/10.1038/s41420-022-01285-x

Ejemplares similares

SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
por: Bortner, Carl, et al.
Publicado: (2019)

Ions, the Movement of Water and the Apoptotic Volume Decrease
por: Bortner, Carl D., et al.
Publicado: (2020)

One Hormone for Two Receptors: Exploring Glucocorticoid Actions Mediated by the Glucocorticoid and Mineralocorticoid Receptors
por: Petrillo, Maria G, et al.
Publicado: (2021)

Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo
por: Karpel-Massler, Georg, et al.
Publicado: (2015)

Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells
por: Miller, Aaron L, et al.
Publicado: (2014)

Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death
por: Eichhorn, J M, et al.
Publicado: (2013)

BCL-w: apoptotic and non-apoptotic role in health and disease
por: Hartman, Mariusz L., et al.
Publicado: (2020)

Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells
por: Zhou, Weihua, et al.
Publicado: (2015)

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy
por: García-Aranda, Marilina, et al.
Publicado: (2018)

Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia
por: de Groot, Anne P., et al.
Publicado: (2021)

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
por: Choudhary, G S, et al.
Publicado: (2015)

Salidroside overcomes dexamethasone resistance in T-acute lymphoblastic leukemia cells
por: Niu, Ya-Na, et al.
Publicado: (2021)

Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells
por: Park, Doyeon, et al.
Publicado: (2021)

Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
por: Kapoor, Isha, et al.
Publicado: (2020)

Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2020)

Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies
por: Juilland, Mélanie, et al.
Publicado: (2016)

Corrigendum: Increased Melanoma-Associated Antigen C2 Expression Affords Resistance to Apoptotic Deathin Suspension-Cultured Tumor Cells
por: Park, Doyeon, et al.
Publicado: (2022)

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
por: thor Straten, Per, et al.
Publicado: (2010)

The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance
por: Barbone, D, et al.
Publicado: (2011)

Evolution of the BCL-2-Regulated Apoptotic Pathway
por: Aouacheria, Abdel, et al.
Publicado: (2016)

CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance
por: Kang, Hong Soon, et al.
Publicado: (2013)

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
por: Chong, Stephen Jun Fei, et al.
Publicado: (2023)

After 62 years of regulating immunity, dexamethasone meets COVID-19
por: Cain, Derek W., et al.
Publicado: (2020)

Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
por: Yue, XiaoYan, et al.
Publicado: (2020)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

Anti-apoptotic effect of dexamethasone in an ototoxicity model
por: Lee, Jin Ho, et al.
Publicado: (2017)

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2021)

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer
por: Lopez, Andrea, et al.
Publicado: (2022)

Anti-apoptotic BCL-2 family members in development
por: Opferman, Joseph T, et al.
Publicado: (2018)

STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells
por: Nagy, Zsuzsanna S, et al.
Publicado: (2009)

Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B
por: Rooswinkel, R W, et al.
Publicado: (2012)

The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance
por: Fitzgerald, Marie-Claire, et al.
Publicado: (2023)

Nrz but not zBcl-xL antagonizes Bcl-wav pro-apoptotic activity in zebrafish
por: Prudent, Julien, et al.
Publicado: (2014)

Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X(L)–Specific Degrader DT2216
por: Thummuri, Dinesh, et al.
Publicado: (2022)

Affordances and Landscapes: Overcoming the Nature–Culture Dichotomy through Niche Construction Theory
por: Heras-Escribano, Manuel, et al.
Publicado: (2018)

988. Overcoming Prescriber Concerns through Successful Access and Affordability of PrEP
por: Whelchel, Kristen, et al.
Publicado: (2020)

Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate
por: Bogdał, Marta N, et al.
Publicado: (2013)

Attenuation of both apoptotic and necrotic actions of cadmium by Bcl-2.
por: Ishido, Masami, et al.
Publicado: (2002)

Expression of Apoptotic Markers Bcl-2 and Bax in the Vascular Wall
por: Klimentova, E.A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gv1lbfpacmgo6nqe4aecvhefj8